AQR Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.46M Sell
91,008
-18,728
-17% -$629K ﹤0.01% 2217
2025
Q4
$4.7M Buy
109,736
+53,135
+94% +$2M ﹤0.01% 1593
2025
Q3
$1.6M Buy
56,601
+46,563
+464% +$1.39M ﹤0.01% 2124
2025
Q2
$188K Sell
10,038
-588
-6% -$11.1K ﹤0.01% 3063
2025
Q1
$191K Buy
+10,626
New +$216K ﹤0.01% 2901
2022
Q2
Sell
-3,111
Closed -$93K 2280
2022
Q1
$93K Sell
3,111
-1,488
-32% -$40.3K ﹤0.01% 2143
2021
Q4
$122K Hold
4,599
﹤0.01% 2133
2021
Q3
$167K Hold
4,599
﹤0.01% 2164
2021
Q2
$200K Hold
4,599
﹤0.01% 2143
2021
Q1
$157K Sell
4,599
-345
-7% -$13.7K ﹤0.01% 2136
2020
Q4
$173K Buy
4,944
+2,520
+104% +$73K ﹤0.01% 2107
2020
Q3
$58K Buy
+2,424
New +$59.5K ﹤0.01% 2165
2019
Q1
Sell
-3,939
Closed -$91K 2212
2018
Q4
$91K Sell
3,939
-2,239
-36% -$63.2K ﹤0.01% 2151
2018
Q3
$198K Buy
6,178
+2,496
+68% +$74.9K ﹤0.01% 2195
2018
Q2
$104K Buy
+3,682
New +$131K ﹤0.01% 2290
2015
Q2
Sell
-2,612
Closed -$93K 2252
2015
Q1
$93K Sell
2,612
-17,310
-87% -$475K ﹤0.01% 2083
2014
Q4
$452K Sell
19,922
-9,208
-32% -$186K ﹤0.01% 2015
2014
Q3
$565K Sell
29,130
-32,870
-53% -$929K ﹤0.01% 1896
2014
Q2
$2.25M Sell
62,000
-9,770
-14% -$332K 0.01% 1228
2014
Q1
$2.79M Buy
71,770
+16,320
+29% +$582K 0.01% 1121
2013
Q4
$1.58M Buy
55,450
+15,870
+40% +$466K ﹤0.01% 1490
2013
Q3
$1.42M Sell
39,580
-1,840
-4% -$67.2K 0.01% 1466
2013
Q2
$1.38M Buy
+41,420
New +$1.88M ﹤0.01% 1410

Other funds holding RIGL